Latest Breaking News On - Sleep disturbance score - Page 1 : comparemela.com

AIM ImmunoTech Announces FDA Clearance of IND Application to Evaluate Ampligen in Phase 2 Clinical Study for the Treatment of Post-COVID Conditions

AIM ImmunoTech Announces FDA Clearance of IND Application to Evaluate Ampligen in Phase 2 Clinical Study for the Treatment of Post-COVID Conditions
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesJenene thomasThomask equelsCompany on twitterImmunotech incItem short formDrug administrationInitiative solveInvestigational new drugChief executive officerBrain fogFatigue scoreSix minute walk testCognitive function scoreSleep disturbance scorePrivate securities litigation reform act

AIM ImmunoTech (AIM) Announces FDA Clearance of IND Application for Phase 2 of Ampligen

AIM ImmunoTech (AIM) Announces FDA Clearance of IND Application for Phase 2 of Ampligen
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesThomask equelsImmunotech incItem short formDrug administrationInvestigational new drugChief executive officerBrain fogFatigue scoreSix minute walk testCognitive function scoreSleep disturbance score

AIM ImmunoTech Announces FDA Clearance of IND Application

Company expects to commence patient enrollment and dosing in Q1 2023.

United statesThomask equelsCompany on twitterImmunotech incItem short formDrug administrationInitiative solveInvestigational new drugChief executive officerBrain fogFatigue scoreSix minute walk testCognitive function scoreSleep disturbance scoreNyse aimAim immunotech inc